11/1
10:49 am
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
11/1
10:49 am
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
11/1
10:06 am
tvtx
Rating for TVTX
Medium
Report
Rating for TVTX
11/1
10:06 am
tvtx
Rating for TVTX
Medium
Report
Rating for TVTX
10/21
08:07 am
tvtx
Travere Therapeutics, Inc. (NASDAQ: TVTX) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $27.00 price target on the stock, up previously from $9.00.
Low
Report
Travere Therapeutics, Inc. (NASDAQ: TVTX) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $27.00 price target on the stock, up previously from $9.00.
10/21
07:21 am
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
10/21
07:21 am
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
10/16
10:51 am
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
10/16
10:51 am
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
10/16
08:44 am
tvtx
Travere Therapeutics, Inc. (NASDAQ: TVTX) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
Low
Report
Travere Therapeutics, Inc. (NASDAQ: TVTX) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
10/16
08:44 am
tvtx
Travere Therapeutics, Inc. (NASDAQ: TVTX) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
Low
Report
Travere Therapeutics, Inc. (NASDAQ: TVTX) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
10/11
09:40 am
tvtx
Rating for TVTX
Medium
Report
Rating for TVTX
10/9
01:03 pm
tvtx
Rating for TVTX
Medium
Report
Rating for TVTX
10/9
01:03 pm
tvtx
Rating for TVTX
Medium
Report
Rating for TVTX
10/9
09:52 am
tvtx
Rating for TVTX
Medium
Report
Rating for TVTX
10/9
09:52 am
tvtx
Rating for TVTX
Medium
Report
Rating for TVTX
10/8
09:34 am
tvtx
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "outperform" rating re-affirmed by analysts at Leerink Partners. They now have a $20.00 price target on the stock.
Low
Report
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "outperform" rating re-affirmed by analysts at Leerink Partners. They now have a $20.00 price target on the stock.
10/8
09:22 am
tvtx
Rating for TVTX
Medium
Report
Rating for TVTX
10/1
11:41 am
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
10/1
11:41 am
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
9/30
11:24 am
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
9/27
02:56 pm
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
9/27
02:56 pm
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
9/27
01:15 pm
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
9/27
01:15 pm
tvtx
Rating for TVTX
Low
Report
Rating for TVTX